FormlyAI is a technology company.
FormlyAI has raised $2.0M across 1 funding round.
FormlyAI has raised $2.0M in total across 1 funding round.
FormlyAI has raised $2.0M in total across 1 funding round.
FormlyAI's investors include Gradient Ventures.
FormlyAI is a technology company that builds AI-powered software solutions to simplify medical device regulatory compliance, particularly for startups and small companies aiming for CE marking and FDA approval. Their main product is an electronic Quality Management System (eQMS) designed to streamline the creation of regulatory documentation and certification processes for medical devices, helping companies navigate complex EU MDR and FDA regulations efficiently. FormlyAI serves medical device manufacturers, especially startups, by reducing the time, cost, and uncertainty involved in regulatory certification, thus accelerating their time to market[1][2][3][4].
FormlyAI was founded in 2021 (some sources mention 2024, but 2021 is more consistent) in Charleston, South Carolina, by Spencer Todd and Severin Högl. Spencer Todd brings extensive experience as a medical device consultant with a background in US FDA approvals, while Severin Högl has firsthand experience in healthcare startups and medical device CE marking. The idea emerged from their combined expertise and the recognized need for accessible, startup-friendly regulatory compliance tools. Early traction came from addressing the underserved startup segment in medical device certification, differentiating from traditional vendors focused on larger companies[1][2][3].
FormlyAI rides the growing trend of digital transformation and AI adoption in regulatory technology (RegTech), particularly in the highly regulated medical device sector. The timing is critical as regulatory requirements like the EU MDR have become more stringent, increasing the complexity and cost of compliance. Startups face significant barriers to entry due to these regulations, and FormlyAI’s AI-driven, startup-friendly approach addresses this pain point. By lowering compliance hurdles, FormlyAI facilitates faster innovation cycles and broader access to medical device markets, influencing the ecosystem by enabling more startups to bring products to market efficiently[1][2][4].
Looking ahead, FormlyAI is positioned to expand its market share by deepening AI capabilities and broadening regulatory coverage globally. Trends such as increasing regulatory complexity, rising demand for digital health solutions, and AI adoption in compliance workflows will shape its growth. As the company matures, it may evolve into a comprehensive virtual regulatory officer platform, further reducing reliance on costly consultants. Its influence will likely grow as it empowers more startups to navigate regulatory landscapes confidently, accelerating innovation in medical technology[3][4].
FormlyAI’s mission to make medical device certification easy and accessible ties back to its founding vision of democratizing regulatory compliance for startups worldwide.
FormlyAI has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2025 | $2.0M Seed | Gradient Ventures |